170 related articles for article (PubMed ID: 33360196)
21. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives.
Wang DY; Li YW; Zhang LH; Lv LY; Zhao YQ; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2020 Dec; 30(24):127652. PubMed ID: 33130293
[TBL] [Abstract][Full Text] [Related]
23. Novel nannocystin A analogues as anticancer therapeutics: Synthesis, biological evaluations and structure-activity relationship studies.
Liu Q; Yang X; Ji J; Zhang SL; He Y
Eur J Med Chem; 2019 May; 170():99-111. PubMed ID: 30878835
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways.
Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN
Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374
[TBL] [Abstract][Full Text] [Related]
25. Solution-phase synthesis and biological evaluation of triostin A and its analogues.
Hattori K; Koike K; Okuda K; Hirayama T; Ebihara M; Takenaka M; Nagasawa H
Org Biomol Chem; 2016 Feb; 14(6):2090-111. PubMed ID: 26779679
[TBL] [Abstract][Full Text] [Related]
26. Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.
Chu PC; Wu YC; Chen CY; Hung YS; Chang CS
Future Med Chem; 2021 Jun; 13(12):1057-1072. PubMed ID: 33896195
[No Abstract] [Full Text] [Related]
27. Exploring the physicochemical and antiproliferative properties of biaryl-linked [13]-macrodilactones.
Chen C; Bosko C; McGeough CP; McLean R; Zaino AM; Kyle Hadden M; Peczuh MW
Bioorg Med Chem; 2020 Oct; 28(20):115671. PubMed ID: 33069068
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
Xia Y; Duan Q; Zhao BH; Li DF; Hou RB
Med Chem; 2016; 12(4):338-46. PubMed ID: 26548744
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
Sun B; Liu J; Gao Y; Zheng HB; Li L; Hu QW; Yuan HQ; Lou HX
Eur J Med Chem; 2017 Aug; 136():603-618. PubMed ID: 28570977
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic Activity and Structure-Activity Relationship of Triazole-Containing Bis(Aryl Ether) Macrocycles.
Hernández-Vázquez E; Chávez-Riveros A; Romo-Pérez A; Ramírez-Apán MT; Chávez-Blanco AD; Morales-Bárcenas R; Dueñas-González A; Miranda LD
ChemMedChem; 2018 Jun; 13(12):1193-1209. PubMed ID: 29771004
[TBL] [Abstract][Full Text] [Related]
31. Syntheses and bioactivities of macrocyclic paclitaxel bis-lactones.
Liu C; Schilling JK; Ravindra R; Bane S; Kingston DG
Bioorg Med Chem; 2004 Dec; 12(23):6147-61. PubMed ID: 15519159
[TBL] [Abstract][Full Text] [Related]
32. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
33. 2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancer.
Xu H; Zhang J; Zhuang J; Chen Y; Chen L; Wang J; Cao R; Liu F; Wang K; Zhang X; Wang L; Chen G
Bioorg Chem; 2024 Jun; 147():107419. PubMed ID: 38703440
[TBL] [Abstract][Full Text] [Related]
34. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives.
Larroque AL; Dubois J; Thoret S; Aubert G; Chiaroni A; Guéritte F; Guénard D
Bioorg Med Chem; 2007 Jan; 15(1):563-74. PubMed ID: 17064914
[TBL] [Abstract][Full Text] [Related]
35. Novel hypoxia-targeting Pt(iv) prodrugs.
Xu Z; Zhao J; Gou S; Xu G
Chem Commun (Camb); 2017 Mar; 53(26):3749-3752. PubMed ID: 28303266
[TBL] [Abstract][Full Text] [Related]
36. HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.
He G; Pan X; Liu X; Zhu Y; Ma Y; Du C; Liu X; Mao C
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48296-48309. PubMed ID: 33054172
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway.
Wu J; Zhang ZH; Zhang LH; Jin XJ; Ma J; Piao HR
Bioorg Med Chem Lett; 2019 Mar; 29(6):853-858. PubMed ID: 30728113
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors.
Li G; Dong H; Ma Y; Shao K; Li Y; Wu X; Wang S; Shao Y; Zhao W
Bioorg Med Chem Lett; 2019 Aug; 29(16):2327-2331. PubMed ID: 31281016
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of indeno[2,1-c]pyrazolones for use as inhibitors against hypoxia-inducible factor (HIF)-1 transcriptional activity.
Fuse S; Suzuki K; Kuchimaru T; Kadonosono T; Ueda H; Sato S; Kizaka-Kondoh S; Nakamura H
Bioorg Med Chem; 2020 Jan; 28(1):115207. PubMed ID: 31740202
[TBL] [Abstract][Full Text] [Related]
40. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
